SRC and colorectal cancer: Results of our studies of the DLD1 cells suggest that loss of the non-catalytic inhibitory mechanism of Chk resulting from suppression of its expression, contributes to Src over-activation and in turn to colorectal cancer tumorigenesis and progression.